TickerFiles

Camp4 Therapeutics Corp

Nasdaq · CIK 0001736730 · Fiscal year end 1231

CAMP

Latest reported period: Latest published period

Revenue

$1.3M

Operating Income

$-13.1M

Net Income

$-18.3M

Recent financials

MetricCurrentPriorChange
Revenue$1.3M--
Operating Income$-13.1M--
Net Income$-18.3M--
Eps Basic-0.32--
Eps Diluted-0.32--
Cash And Equivalents$99.2M--
Total Assets$105.5M--
Total Liabilities$74.6M--
Shareholders Equity$30.9M--
Operating Cash Flow$-11.0M--
Capital Expenditures$0--

Latest filings

FormCompanyFiledAccession
10-QCamp4 Therapeutics Corp2026-05-070001628280-26-032146
10-KCamp4 Therapeutics Corp2026-03-050001736730-26-000016
10-QCamp4 Therapeutics Corp2025-11-060001736730-25-000094
4Camp4 Therapeutics Corp2025-09-150001598549-25-000004
4Camp4 Therapeutics Corp2025-09-150001231919-25-000196
4Camp4 Therapeutics Corp2025-09-110001193125-25-201380
4Camp4 Therapeutics Corp2025-09-110001881045-25-000003
4Camp4 Therapeutics Corp2025-09-110002033333-25-000003
4Camp4 Therapeutics Corp2025-09-110001927058-25-000002
4Camp4 Therapeutics Corp2025-09-110001490283-25-000003
4Camp4 Therapeutics Corp2025-09-110001193125-25-201392
10-QCamp4 Therapeutics Corp2025-08-140001736730-25-000070